Orchestra BioMed Holdings, Inc. (OBIO)

Orchestra BioMed Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	20.47	34.69	22.26	30.56	19.78	9.94
Short-Term Investments	89.49	71.82	44.55	57.04	64	0.96
Cash & Short-Term Investments	109.96	106.51	66.81	87.6	83.79	10.9
Cash Growth	224.14%	59.42%	-23.73%	4.55%	668.95%	-69.56%
Receivables	0.05	0.1	0.09	0.1	0.1	0.12
Inventory	0.25	0.31	0.17	0.15	0.28	0.07
Prepaid Expenses	0.98	0.99	2.09	1.27	0.53	0.23
Total Current Assets	111.24	107.91	69.17	89.11	84.69	11.32
Property, Plant & Equipment	3.22	3.21	3.49	2.83	3.68	1.12
Long-Term Investments	-	2.5	2.5	2.5	2.5	0.4
Long-Term Deferred Charges	-	-	-	-	4	0.1
Other Long-Term Assets	1.24	1.24	1.02	0.77	0.71	0.59
Total Assets	115.7	114.86	76.17	95.21	95.57	13.53

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	6.13	6.1	5.13	2.9	3.97	2.03
Accrued Expenses	6.53	9.89	6.08	5.15	5.38	1.89
Current Portion of Long-Term Debt	-	-	-	-	-	2
Current Portion of Leases	0.81	0.75	0.55	0.65	0.7	-
Current Unearned Revenue	-	-	4.44	2.51	6.44	5.54
Other Current Liabilities	-	-	-	-	2.09	0.78
Total Current Liabilities	13.47	16.74	16.21	11.21	18.57	12.24
Long-Term Debt	69.43	30.75	14.29	-	9.49	3.67
Long-Term Leases	0.52	0.94	1.69	1.04	1.68	-
Long-Term Unearned Revenue	-	-	10.99	14.92	13.1	16.86
Other Long-Term Liabilities	2.86	3.06	0.04	-	0.2	0.54
Total Liabilities	86.28	51.48	43.22	27.17	43.04	33.31

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.01	0.01	0	0	0	-
Additional Paid-In Capital	426.42	416.08	342.78	316.9	252.27	94.89
Retained Earnings	-407.03	-362.58	-309.88	-248.85	-199.73	-166.13
Comprehensive Income & Other	-0.08	0.06	0.05	-0.01	-0.01	-
Total Common Equity	19.32	53.57	32.96	68.04	52.53	-71.23
Shareholders' Equity	29.42	63.38	32.96	68.04	52.53	-19.78
Total Liabilities & Equity	115.7	114.86	76.17	95.21	95.57	13.53

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	70.76	32.44	16.53	1.69	11.87	5.67
Net Cash (Debt)	39.2	74.08	50.28	85.91	71.92	5.22
Net Cash Growth	123.13%	47.32%	-41.47%	19.46%	1276.89%	-80.17%
Net Cash Per Share	0.66	1.55	1.37	2.59	4.80	2.47
Filing Date Shares Outstanding	60.11	58.52	38.31	35.78	2.52	2.19
Total Common Shares Outstanding	60.11	57.03	38.19	35.78	2.52	2.19
Working Capital	97.77	91.18	52.96	77.91	66.12	-0.92
Book Value Per Share	0.32	0.94	0.86	1.90	20.83	-32.60
Tangible Book Value	19.32	53.57	32.96	68.04	52.53	-71.23
Tangible Book Value Per Share	0.32	0.94	0.86	1.90	20.83	-32.60
Machinery	3.69	3.19	2.53	2.12	2.08	1.51
Construction In Progress	-	-	-	-	-	0.02
Leasehold Improvements	0.17	0.16	0.16	0.2	0.19	0.18

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 10, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 27, 2026

Data Sources Report a data error